Coptisine up-regulates miR-146a-5p expression to attenuate injury of Parkinson's disease cell models induced by 1-methyl-4-phenylpy ridinium via PI3K/AKT pathway
Hongli Chen, Huijuan Liang, Yan Li
Abstract
Hongli Chen, Huijuan Liang, Yan Li
Abstract
Objective To investigate the effect of coptisine on 1-methyl-4-phenylpy ridinium(MPP+) induced Parkinson's disease (PD) cell injury and its mechanism. Methods SK-N-SH cells were treated with 0.3 mmol/L MPP+ to induce PD cell models (MPP+ group); normal cultured cells were used as blank controls (NCs); pretreatment with coptisine at concentrations of 10, 20, and 40 μmol/L for 4 h was performed after giving 0.3 mmol/L MPP+, different concentration coptisine treatment groups were named. And miR-con and miR-146a-5p were transfected into SK-N-SH cells and treated with 0.3 mmol/L MPP+, and named MPP++miR-con group and MPP++miR-146a-5p group; anti-miR-con and anti-miR-146a-5p were transfected into SK-N-SH cells and pretreated with 20 μmol/L coptisine for 4 h, and then, treated with 0.3 mmol/L MPP+, and named MPP++Cop+anti-miR-con group and MPP++Cop+anti-miR-146a-5p group. Cell viability was determined by MTT assay; Western blotting was used to detect the protein expressions of cleaved cysteine-containing aspartate-specific proteases-3 (caspase-3), CyclinD1, phosphorylated protein kinase B (p-AKT), p-phosphoinositide 3 kinase (p-PI3K); apoptosis was detected by flow cytometry; real-time quantitative PCR (RT-qPCR) was used to detect the miR-146a-5p expression. Results As compared with the NCs, the MPP+ induced SK-N-SH cells had significantly decreased viability and CyclinD1 and miR-146a-5p expressions, and significantly increased cleaved caspase-3 expression and apoptosis rate (P<0.05). After coptisine treatment and miR-146a-5p overexpression, MPP+ induced SK-N-SH cells had significantly increased viability and expressions of CyclinD1 and miR-146a-5p, and significantly decreased cleaved-caspase-3 expression and apoptosis rate (P<0.05). Low expression of miR-146a-5p reversed the effect of coptisine on proliferation promotion and apoptosis inhibition of SK-N-SH cells. The expression levels of p-AKT and p-PI3K in MPP+-induced SK-N-SH cells were significantly increased after coptisine treatment. Low expression of miR-146a-5p reversed the effect of coptisine on expressions of p-AKT and p-PI3K. Conclusion Coptisine can promote cell survival and inhibit MPP+-induced apoptosis, which may be related to miR-146a-5p and PI3K/AKT signaling pathways. Key words: Coptisine; MiR-146a-5p; PI3K/AKT signaling pathway; Parkinson's disease; Cell injury
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect of coptisine on 1-methyl-4-phenylpy ridinium(MPP+) induced Parkinson's disease (PD) cell injury and its mechanism. Methods SK-N-SH cells were treated with 0.3 mmol/L MPP+ to induce PD cell models (MPP+ group); normal cultured cells were used as blank controls (NCs); pretreatment with coptisine at concentrations of 10, 20, and 40 μmol/L for 4 h was performed after giving 0.3 mmol/L MPP+, different concentration coptisine treatment groups were named. And miR-con and miR-146a-5p were transfected into SK-N-SH cells and treated with 0.3 mmol/L MPP+, and named MPP++miR-con group and MPP++miR-146a-5p group; anti-miR-con and anti-miR-146a-5p were transfected into SK-N-SH cells and pretreated with 20 μmol/L coptisine for 4 h, and then, treated with 0.3 mmol/L MPP+, and named MPP++Cop+anti-miR-con group and MPP++Cop+anti-miR-146a-5p group. Cell viability was determined by MTT assay; Western blotting was used to detect the protein expressions of cleaved cysteine-containing aspartate-specific proteases-3 (caspase-3), CyclinD1, phosphorylated protein kinase B (p-AKT), p-phosphoinositide 3 kinase (p-PI3K); apoptosis was detected by flow cytometry; real-time quantitative PCR (RT-qPCR) was used to detect the miR-146a-5p expression. Results As compared with the NCs, the MPP+ induced SK-N-SH cells had significantly decreased viability and CyclinD1 and miR-146a-5p expressions, and significantly increased cleaved caspase-3 expression and apoptosis rate (P<0.05). After coptisine treatment and miR-146a-5p overexpression, MPP+ induced SK-N-SH cells had significantly increased viability and expressions of CyclinD1 and miR-146a-5p, and significantly decreased cleaved-caspase-3 expression and apoptosis rate (P<0.05). Low expression of miR-146a-5p reversed the effect of coptisine on proliferation promotion and apoptosis inhibition of SK-N-SH cells. The expression levels of p-AKT and p-PI3K in MPP+-induced SK-N-SH cells were significantly increased after coptisine treatment. Low expression of miR-146a-5p reversed the effect of coptisine on expressions of p-AKT and p-PI3K. Conclusion Coptisine can promote cell survival and inhibit MPP+-induced apoptosis, which may be related to miR-146a-5p and PI3K/AKT signaling pathways. Key words: Coptisine; MiR-146a-5p; PI3K/AKT signaling pathway; Parkinson's disease; Cell injury
Key concepts: Coptisine, Viability assay, Molecular biology, Protein kinase B, Apoptosis, Chemistry, Flow cytometry, Western blot